For example, taxol treatment causes GSDMD-mediated pyroptosis in nasopharyngeal carcinoma, whereas suppression of pyroptosis has been proposed to be associated with taxol resistance in nasopharyngeal carcinoma [117]. Here, GSDMD is linked to nasopharyngeal carcinoma.